Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2022-04-28 Sale |
2022-05-02 8:24 pm |
Relay Therapeutics Inc. | RLAY | Bergstrom Donald A President, R&D |
14,811 | $24.74 | $366,367 | 278,949 (Direct) |
View |
| 2022-04-28 Sale |
2022-05-02 8:13 pm |
Relay Therapeutics Inc. | RLAY | Porter Andy Chief Administrative Officer |
435 | $25.57 | $11,123 | 46,588 (Direct) |
View |
| 2022-04-28 Sale |
2022-05-02 8:07 pm |
Relay Therapeutics Inc. | RLAY | Catinazzo Thomas Chief Financial Officer |
725 | $25.57 | $18,538 | 53,252 (Direct) |
View |
| 2022-04-28 Sale |
2022-05-02 8:03 pm |
Relay Therapeutics Inc. | RLAY | Adams Brian Chief Legal Officer |
708 | $25.57 | $18,104 | 63,876 (Direct) |
View |
| 2022-04-12 Sale |
2022-04-14 9:20 pm |
Relay Therapeutics Inc. | RLAY | Patel Sanjiv President and CEO |
84,000 | $31.42 | $2,639,280 | 2,067,473 (Direct) |
View |
| 2022-04-01 Sale |
2022-04-05 5:32 pm |
Relay Therapeutics Inc. | RLAY | Bergstrom Donald A President, R&D |
18,000 | $30.32 | $545,760 | 293,760 (Direct) |
View |
| 2022-03-29 Sale |
2022-03-31 5:49 pm |
Relay Therapeutics Inc. | RLAY | Porter Andy Chief Administrative Officer |
294 | $29.87 | $8,782 | 47,023 (Direct) |
View |
| 2022-03-29 Sale |
2022-03-31 5:45 pm |
Relay Therapeutics Inc. | RLAY | Catinazzo Thomas Chief Financial Officer |
282 | $29.87 | $8,423 | 53,977 (Direct) |
View |
| 2022-03-29 Sale |
2022-03-31 5:41 pm |
Relay Therapeutics Inc. | RLAY | Bergstrom Donald A President, R&D |
622 | $29.87 | $18,579 | 94,304 (Direct) |
View |
| 2022-03-29 Sale |
2022-03-31 5:37 pm |
Relay Therapeutics Inc. | RLAY | Adams Brian Chief Legal Officer |
333 | $29.87 | $9,947 | 64,584 (Direct) |
View |
| 2022-03-24 Sale |
2022-03-28 8:18 pm |
Relay Therapeutics Inc. | RLAY | Catinazzo Thomas Chief Financial Officer |
13,286 | $30 | $398,580 | 80,516 (Direct) |
View |
| 2022-03-24 Sale |
2022-03-28 8:11 pm |
Relay Therapeutics Inc. | RLAY | Bergstrom Donald A President, R&D |
10,000 | $30 | $300,000 | 312,382 (Direct) |
View |
| 2022-03-10 Sale |
2022-03-11 7:02 pm |
Relay Therapeutics Inc. | RLAY | Bergstrom Donald A President, R&D |
10,000 | $25 | $250,000 | 322,382 (Direct) |
View |
| 2022-03-01 Sale |
2022-03-03 5:31 pm |
Relay Therapeutics Inc. | RLAY | Bergstrom Donald A President, R&D |
8,000 | $23.88 | $191,040 | 332,382 (Direct) |
View |
| 2022-02-22 Sale |
2022-02-22 9:01 pm |
Relay Therapeutics Inc. | RLAY | Bergstrom Donald A President, R&D |
22,994 | $20.94 | $481,577 | 340,382 (Direct) |
View |
| 2021-12-27 Sale |
2021-12-27 7:50 pm |
Relay Therapeutics Inc. | RLAY | Porter Andy See Remarks |
260 | $33.1 | $8,606 | 23,147 (Direct) |
View |
| 2021-12-27 Sale |
2021-12-27 7:43 pm |
Relay Therapeutics Inc. | RLAY | Catinazzo Thomas Senior Vice President, Finance |
295 | $33.1 | $9,765 | 14,989 (Direct) |
View |
| 2021-12-27 Sale |
2021-12-27 7:39 pm |
Relay Therapeutics Inc. | RLAY | Bergstrom Donald A See Remarks |
649 | $33.1 | $21,482 | 44,970 (Direct) |
View |
| 2021-12-27 Sale |
2021-12-27 7:31 pm |
Relay Therapeutics Inc. | RLAY | Adams Brian General Counsel |
295 | $33.1 | $9,765 | 24,989 (Direct) |
View |
| 2021-11-15 Sale |
2021-11-16 7:14 pm |
Relay Therapeutics Inc. | RLAY | Catinazzo Thomas Senior Vice President, Finance |
22,500 | $35.4 | $796,500 | 54,827 (Direct) |
View |
| 2021-11-15 Sale |
2021-11-16 7:07 pm |
Relay Therapeutics Inc. | RLAY | Adams Brian General Counsel |
6,500 | $35.42 | $230,230 | 166,070 (Direct) |
View |
| 2021-10-15 Sale |
2021-10-19 8:56 pm |
Relay Therapeutics Inc. | RLAY | Bergstrom Donald A See Remarks |
30,000 | $34.15 | $1,024,500 | 45,619 (Direct) |
View |
| 2021-09-27 Sale |
2021-09-27 9:33 pm |
Relay Therapeutics Inc. | RLAY | Catinazzo Thomas Senior Vice President, Finance |
293 | $36.87 | $10,803 | 15,284 (Direct) |
View |
| 2021-09-27 Sale |
2021-09-27 9:27 pm |
Relay Therapeutics Inc. | RLAY | Bergstrom Donald A See Remarks |
646 | $36.87 | $23,818 | 75,619 (Direct) |
View |
| 2021-09-27 Sale |
2021-09-27 9:21 pm |
Relay Therapeutics Inc. | RLAY | Adams Brian General Counsel |
293 | $36.87 | $10,803 | 25,284 (Direct) |
View |
| 2021-09-13 Sale |
2021-09-13 8:27 pm |
Relay Therapeutics Inc. | RLAY | Adams Brian General Counsel |
6,500 | $35.02 | $227,630 | 172,863 (Direct) |
View |
| 2021-09-13 Sale |
2021-09-13 8:24 pm |
Relay Therapeutics Inc. | RLAY | Catinazzo Thomas Senior Vice President, Finance |
22,500 | $35 | $787,500 | 77,620 (Direct) |
View |
| 2021-06-28 Sale |
2021-06-30 6:28 pm |
Relay Therapeutics Inc. | RLAY | Adams Brian General Counsel |
293 | $35.81 | $10,492 | 25,577 (Direct) |
View |
| 2021-06-28 Sale |
2021-06-30 6:26 pm |
Relay Therapeutics Inc. | RLAY | Catinazzo Thomas Senior Vice President, Finance |
293 | $35.81 | $10,492 | 15,577 (Direct) |
View |
| 2021-06-28 Sale |
2021-06-30 6:25 pm |
Relay Therapeutics Inc. | RLAY | Bergstrom Donald A See Remarks |
976 | $35.81 | $34,951 | 76,265 (Direct) |
View |
| 2021-06-16 Sale |
2021-06-17 7:38 pm |
Relay Therapeutics Inc. | RLAY | Bergstrom Donald A See Remarks |
42,242 | $33.75 | $1,425,668 | 330,697 (Direct) |
View |
| 2021-06-07 Sale |
2021-06-09 8:37 pm |
Relay Therapeutics Inc. | RLAY | Adams Brian General Counsel |
6,500 | $35 | $227,500 | 179,656 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2022-05-02 Exercise |
2022-05-02 8:24 pm |
N/A 2028-04-09 |
Relay Therapeutics Inc. | RLAY | Bergstrom Donald A President, R&D |
13,000 | $0 | 278,949 (Direct) |
View |
| 2022-05-02 Exercise |
2022-05-02 8:24 pm |
N/A N/A |
Relay Therapeutics Inc. | RLAY | Bergstrom Donald A President, R&D |
13,000 | $4.12 | 278,949 (Direct) |
View |
| 2022-04-12 Exercise |
2022-04-14 9:20 pm |
N/A 2028-03-22 |
Relay Therapeutics Inc. | RLAY | Patel Sanjiv President and CEO |
84,000 | $0 | 2,067,473 (Direct) |
View |
| 2022-04-13 Exercise |
2022-04-14 9:20 pm |
N/A N/A |
Relay Therapeutics Inc. | RLAY | Patel Sanjiv President and CEO |
28,000 | $5.04 | 2,067,473 (Direct) |
View |
| 2022-04-12 Exercise |
2022-04-14 9:20 pm |
N/A N/A |
Relay Therapeutics Inc. | RLAY | Patel Sanjiv President and CEO |
56,000 | $4.12 | 2,067,473 (Direct) |
View |
| 2022-04-01 Exercise |
2022-04-05 5:32 pm |
N/A 2028-04-09 |
Relay Therapeutics Inc. | RLAY | Bergstrom Donald A President, R&D |
18,000 | $0 | 293,760 (Direct) |
View |
| 2022-04-01 Exercise |
2022-04-05 5:32 pm |
N/A N/A |
Relay Therapeutics Inc. | RLAY | Bergstrom Donald A President, R&D |
18,000 | $4.12 | 293,760 (Direct) |
View |
| 2022-03-24 Exercise |
2022-03-28 8:18 pm |
N/A 2028-04-09 |
Relay Therapeutics Inc. | RLAY | Catinazzo Thomas Chief Financial Officer |
13,286 | $0 | 80,516 (Direct) |
View |
| 2022-03-24 Exercise |
2022-03-28 8:18 pm |
N/A N/A |
Relay Therapeutics Inc. | RLAY | Catinazzo Thomas Chief Financial Officer |
13,286 | $4.12 | 80,516 (Direct) |
View |
| 2022-03-24 Exercise |
2022-03-28 8:11 pm |
N/A 2028-04-09 |
Relay Therapeutics Inc. | RLAY | Bergstrom Donald A President, R&D |
10,000 | $0 | 312,382 (Direct) |
View |
| 2022-03-24 Exercise |
2022-03-28 8:11 pm |
N/A N/A |
Relay Therapeutics Inc. | RLAY | Bergstrom Donald A President, R&D |
10,000 | $4.12 | 312,382 (Direct) |
View |
| 2022-03-10 Exercise |
2022-03-11 7:02 pm |
N/A 2028-04-09 |
Relay Therapeutics Inc. | RLAY | Bergstrom Donald A President, R&D |
10,000 | $0 | 322,382 (Direct) |
View |
| 2022-03-10 Exercise |
2022-03-11 7:02 pm |
N/A N/A |
Relay Therapeutics Inc. | RLAY | Bergstrom Donald A President, R&D |
10,000 | $4.12 | 322,382 (Direct) |
View |
| 2022-03-01 Exercise |
2022-03-03 5:31 pm |
N/A 2028-04-09 |
Relay Therapeutics Inc. | RLAY | Bergstrom Donald A President, R&D |
8,000 | $0 | 332,382 (Direct) |
View |
| 2022-03-01 Exercise |
2022-03-03 5:31 pm |
N/A N/A |
Relay Therapeutics Inc. | RLAY | Bergstrom Donald A President, R&D |
8,000 | $4.12 | 332,382 (Direct) |
View |
| 2022-02-22 Exercise |
2022-02-22 9:01 pm |
N/A 2028-04-09 |
Relay Therapeutics Inc. | RLAY | Bergstrom Donald A President, R&D |
8,000 | $0 | 340,382 (Direct) |
View |
| 2022-02-22 Exercise |
2022-02-22 9:01 pm |
N/A N/A |
Relay Therapeutics Inc. | RLAY | Bergstrom Donald A President, R&D |
8,000 | $4.12 | 340,382 (Direct) |
View |
| 2022-01-27 Option Award |
2022-01-31 5:28 pm |
N/A 2032-01-26 |
Relay Therapeutics Inc. | RLAY | Porter Andy Chief Administrative Officer |
72,510 | $0 | 95,657 (Direct) |
View |
| 2022-01-27 Option Award |
2022-01-31 5:25 pm |
N/A 2032-01-26 |
Relay Therapeutics Inc. | RLAY | Patel Sanjiv President and CEO |
527,140 | $0 | 527,140 (Direct) |
View |
| 2022-01-27 Option Award |
2022-01-31 5:21 pm |
N/A 2032-01-26 |
Relay Therapeutics Inc. | RLAY | Catinazzo Thomas Chief Financial Officer |
117,810 | $0 | 132,799 (Direct) |
View |
| 2022-01-27 Option Award |
2022-01-31 5:17 pm |
N/A 2032-01-26 |
Relay Therapeutics Inc. | RLAY | Bergstrom Donald A President, R&D |
194,850 | $0 | 239,820 (Direct) |
View |
| 2022-01-27 Option Award |
2022-01-31 5:13 pm |
N/A 2032-01-26 |
Relay Therapeutics Inc. | RLAY | Adams Brian Chief Legal Officer |
117,810 | $0 | 143,457 (Direct) |
View |
| 2021-12-31 Option Award |
2022-01-07 5:15 pm |
N/A N/A |
Relay Therapeutics Inc. | RLAY | Adams Brian General Counsel |
658 | $26.1 | 25,647 (Direct) |
View |
| 2021-12-31 Option Award |
2022-01-07 5:13 pm |
N/A N/A |
Relay Therapeutics Inc. | RLAY | Patel Sanjiv President and CEO |
658 | $26.1 | 1,361,089 (Direct) |
View |
Ownership |
2021-12-27 6:36 pm |
N/A N/A |
Relay Therapeutics Inc. | RLAY | Porter Andy See Remarks |
0 | $0 | 256,716 (Direct) |
View |
| 2021-11-15 Exercise |
2021-11-16 7:14 pm |
N/A 2028-04-09 |
Relay Therapeutics Inc. | RLAY | Catinazzo Thomas Senior Vice President, Finance |
22,500 | $0 | 54,827 (Direct) |
View |
| 2021-11-15 Exercise |
2021-11-16 7:14 pm |
N/A N/A |
Relay Therapeutics Inc. | RLAY | Catinazzo Thomas Senior Vice President, Finance |
22,500 | $4.12 | 54,827 (Direct) |
View |
| 2021-11-15 Exercise |
2021-11-16 7:07 pm |
N/A 2028-03-22 |
Relay Therapeutics Inc. | RLAY | Adams Brian General Counsel |
6,500 | $0 | 166,070 (Direct) |
View |
| 2021-11-15 Exercise |
2021-11-16 7:07 pm |
N/A N/A |
Relay Therapeutics Inc. | RLAY | Adams Brian General Counsel |
6,500 | $4.12 | 166,070 (Direct) |
View |
| 2021-09-13 Exercise |
2021-09-13 8:27 pm |
N/A 2028-03-22 |
Relay Therapeutics Inc. | RLAY | Adams Brian General Counsel |
6,500 | $0 | 172,863 (Direct) |
View |
| 2021-09-13 Exercise |
2021-09-13 8:27 pm |
N/A N/A |
Relay Therapeutics Inc. | RLAY | Adams Brian General Counsel |
6,500 | $4.12 | 172,863 (Direct) |
View |
| 2021-09-13 Exercise |
2021-09-13 8:24 pm |
N/A 2028-04-09 |
Relay Therapeutics Inc. | RLAY | Catinazzo Thomas Senior Vice President, Finance |
22,500 | $0 | 77,620 (Direct) |
View |
| 2021-09-13 Exercise |
2021-09-13 8:24 pm |
N/A N/A |
Relay Therapeutics Inc. | RLAY | Catinazzo Thomas Senior Vice President, Finance |
22,500 | $4.12 | 77,620 (Direct) |
View |
| 2021-06-16 Exercise |
2021-06-17 7:38 pm |
N/A 2028-04-09 |
Relay Therapeutics Inc. | RLAY | Bergstrom Donald A See Remarks |
42,242 | $0 | 330,697 (Direct) |
View |
| 2021-06-16 Exercise |
2021-06-17 7:38 pm |
N/A N/A |
Relay Therapeutics Inc. | RLAY | Bergstrom Donald A See Remarks |
42,242 | $4.12 | 330,697 (Direct) |
View |
| 2021-06-07 Exercise |
2021-06-09 8:37 pm |
N/A 2028-03-22 |
Relay Therapeutics Inc. | RLAY | Adams Brian General Counsel |
6,500 | $0 | 179,656 (Direct) |
View |
| 2021-06-07 Exercise |
2021-06-09 8:37 pm |
N/A N/A |
Relay Therapeutics Inc. | RLAY | Adams Brian General Counsel |
6,500 | $4.12 | 179,656 (Direct) |
View |